Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-43.58%
0%
-43.58%
6 Months
73.82%
0%
73.82%
1 Year
49.65%
0%
49.65%
2 Years
73.82%
0%
73.82%
3 Years
3.03%
0%
3.03%
4 Years
-52.33%
0%
-52.33%
5 Years
-79.75%
0%
-79.75%
Implanet SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.43%
EBIT Growth (5y)
-3.62%
EBIT to Interest (avg)
-4.42
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
3.95
Sales to Capital Employed (avg)
1.07
Tax Ratio
1.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-32.34
EV to EBIT
-10.27
EV to EBITDA
-13.92
EV to Capital Employed
13.16
EV to Sales
4.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-128.09%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
7.40
8.00
-7.50%
Operating Profit (PBDIT) excl Other Income
-4.80
-2.90
-65.52%
Interest
0.40
0.60
-33.33%
Exceptional Items
-0.30
0.90
-133.33%
Consolidate Net Profit
-6.70
-3.50
-91.43%
Operating Profit Margin (Excl OI)
-827.00%
-516.90%
-31.01%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -7.50% vs 31.15% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -91.43% vs 23.91% in Dec 2022
About Implanet SA 
Implanet SA
Pharmaceuticals & Biotechnology
Implanet SA is a France-based company. It is involved in the design, production and marketing of medical equipment, such as medical implants and devices used in orthopedic surgery. The Company's products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws and anchors, among others. Its brands portfolio includes Spine System and Jazz. The Implanet Spine System aims to provide immobilization and stabilization of the spinal segments in skeletally mature patients as an adjunct to fusion of the thoracic, lumbar and sacral spine. The Implanet Jazz System, its flagship product, is an implant used to improve the treatment of spinal conditions requiring vertebral fusion.
Company Coordinates 
Company Details
Technopole Bordeaux Montesquieu, Allee Francois Magendie MARTILLAC None : 33650
Registrar Details






